4,680 results on '"A. Baruchel"'
Search Results
2. S255: EFFICACY AND SAFETY OF TISAGENLECLEUCEL IN PEDIATRIC AND YOUNG ADULT PATIENTS (PTS) WITH RELAPSED OR REFRACTORY (R/R) MATURE B-CELL NON-HODGKIN LYMPHOMA (NHL): THE PHASE II BIANCA STUDY
3. P360: EFFICACY AND SAFETY OF DARATUMUMAB IN PEDIATRIC AND YOUNG ADULT PATIENTS WITH RELAPSED/REFRACTORY T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA OR LYMPHOBLASTIC LYMPHOMA: RESULTS FROM PHASE 2 DELPHINUS STUDY
4. Impact of childhood leukemia on siblings: their long-term perception of family functioning and its relationship with their psychosocial characteristics using structural equation modeling
5. Is Acute Myeloblastic Leukemia in Children Under 2 Years of Age a Specific Entity? A Report from the FRENCH ELAM02 Study Group
6. Patient-Level Meta-analysis of Clofarabine in Acute Lymphoblastic Leukemia
7. CAR T-cells for T-cell acute lymphoblastic leukemia
8. NGS-based stratification refines the risk stratification in T-ALL and identifies a very-high-risk subgroup of patients
9. Les cellules CAR-T ont-elles tenu leurs promesses dans le traitement des leucémies aiguës en 2024 ?
10. ATM germ line pathogenic variants affect outcomes in children with ataxia-telangiectasia and hematological malignancies
11. Genomic imbalance analysis provides new insight into prognostic factors in adult and pediatric T-ALL
12. Prognostic impact of RUNX1 mutations and deletions in pediatric acute myeloid leukemia: results from the French ELAM02 study group
13. Pharmacokinetics, pharmacodynamics, efficacy, and safety of ravulizumab in pediatric paroxysmal nocturnal hemoglobinuria
14. CAR T-cells for T-cell acute lymphoblastic leukemia
15. TREC mediated oncogenesis in human immature T lymphoid malignancies preferentially involves ZFP36L2
16. Harnessing the MYB-dependent TAL1 5’super-enhancer for targeted therapy in T-ALL
17. A predictive classifier of poor prognosis in transplanted patients with juvenile myelomonocytic leukemia: a study on behalf of the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire
18. Educational outcomes in siblings of childhood leukemia survivors: Factors associated with school difficulties and comparison with general population
19. Daratumumab in pediatric relapsed/refractory acute lymphoblastic leukemia or lymphoblastic lymphoma: the DELPHINUS study
20. Hematopoietic stem cell transplantation for acute lymphoblastic leukemia: why do adolescents and young adults outcomes differ from those of children? A retrospective study on behalf of the Francophone Society of Stem Cell Transplantation and Cellular Therapy (SFGM-TC)
21. TREC mediated oncogenesis in human immature T lymphoid malignancies preferentially involves ZFP36L2
22. A non-symmetric divide-and-conquer recursive formula for the convolution of polynomials and power series
23. A new X-ray beam induced current setup, coupled with X-ray diffraction imaging, for diamonds and semiconductors characterization by synchrotron techniques at ESRF
24. INSPIRED Symposium Part 2: Prevention and Management of Relapse Following Chimeric Antigen Receptor T Cell Therapy for B Cell Acute Lymphoblastic Leukemia
25. Brothers and sisters of childhood acute leukemia survivors: Their long‐term quality of life and its determinants
26. Influence of growth process and crystal defects on sapphire brittleness
27. P321: TNF-MEDIATED CELL DEATH: AN ACTIONABLE TARGET FOR IMMUNOTHERAPY IN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
28. P501: ISATUXIMAB PLUS CHEMOTHERAPY FOR PEDIATRIC RELAPSED/REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA OR ACUTE MYELOID LEUKEMIA (ISAKIDS): INTERIM EFFICACY ANALYSIS
29. P1408: UPDATED RESULTS OF THE PHASE I BALLI-01 TRIAL OF UCART22, AN ANTI-CD22 ALLOGENEIC CAR-T CELL PRODUCT, IN PATIENTS WITH RELAPSED OR REFRACTORY (R/R) CD22+ B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL)
30. Properties of the cumulated deficient binary digit sum
31. Flattening Karatsuba's recursion tree into a single summation
32. An advanced Bragg diffraction imaging technique to characterize defects: The examples of GaN and AlN
33. Harnessing the MYB-dependent TAL1 5’super-enhancer for targeted therapy in T-ALL
34. Place de l’allogreffe de cellules souches hématopoïétiques après traitement par CAR T-cell anti-CD19 : recommandations de la SFGM-TC
35. Oncogenetic landscape of T-cell lymphoblastic lymphomas compared to T-cell acute lymphoblastic leukemia
36. Bridging to CAR-T Cells in Children, Adolescents, and Young Adults with ALL
37. The use of ICU resources in CAR-T cell recipients: a hospital-wide study
38. Down syndrome and leukemia: from basic mechanisms to clinical advances
39. Real-world Experience of Approved Chimeric Antigen Receptor T-cell Therapies Compared to Clinical Trials Data
40. Translating regenerative medicine therapies in neonatal necrotizing enterocolitis
41. Success of donor‐derived CAR‐T cells after failure of autologous CD19 CAR‐T cells (tisagenlecleucel) in B‐cell acute lymphoblastic leukaemia
42. CD19 CAR T-cells for pediatric relapsed acute lymphoblastic leukemia with active CNS involvement: a retrospective international study
43. The interplay between anticancer challenges and the microbial communities from the gut
44. Tisagenlecleucel therapy for relapsed or refractory B-cell acute lymphoblastic leukaemia in infants and children younger than 3 years of age at screening: an international, multicentre, retrospective cohort study
45. Impact of T-cell Receptor Status on Mutational Landscape and Outcome in T-ALL
46. The oncogenetic landscape and clinical impact of BCL11B alterations in adult and pediatric T-cell acute lymphoblastic leukemia
47. The use of ICU resources in CAR-T cell recipients: a hospital-wide study
48. Some conjectural continued fractions
49. EBV-driven lymphoid neoplasms associated with pediatric ALL maintenance therapy
50. Prognostic value of Oncogenetic mutations in pediatric T Acute Lymphoblastic Leukemia: a comparison of UKALL2003 and FRALLE2000T protocols
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.